Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 151
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Arterioscler Thromb Vasc Biol ; 41(3): 1047-1061, 2021 03.
Article in English | MEDLINE | ID: mdl-33504179

ABSTRACT

Shortened telomeres have been linked to numerous chronic diseases, most importantly coronary artery disease, but the underlying mechanisms remain ill defined. Loss-of-function mutations and deletions in telomerase both accelerate telomere shortening but do not necessarily lead to a clinical phenotype associated with atherosclerosis, questioning the causal role of telomere length in cardiac pathology. The differential extranuclear functions of the 2 main components of telomerase, telomerase reverse transcriptase and telomerase RNA component, offer important clues about the complex relationship between telomere length and cardiovascular pathology. In this review, we critically discuss relevant preclinical models, genetic disorders, and clinical studies to elucidate the impact of telomerase in cardiovascular disease and its potential role as a therapeutic target. We suggest that the antioxidative function of mitochondrial telomerase reverse transcriptase might be atheroprotective, making it a potential target for clinical trials. Graphic Abstract: A graphic abstract is available for this article.


Subject(s)
Cardiovascular Diseases/enzymology , Cardiovascular Diseases/therapy , Telomerase/metabolism , Animals , Biomarkers/blood , Cardiovascular Diseases/blood , Clinical Trials as Topic , Drugs, Chinese Herbal/therapeutic use , Exercise , Genome-Wide Association Study , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Leukocytes/enzymology , Mice , Models, Cardiovascular , Mutation , RNA/genetics , Telomerase/blood , Telomerase/genetics , Telomere Homeostasis/physiology , Telomere Shortening/physiology
2.
Mol Genet Genomic Med ; 7(9): e894, 2019 09.
Article in English | MEDLINE | ID: mdl-31393666

ABSTRACT

BACKGROUND: Fabry disease (OMIM 301500) is an X-linked disorder caused by alpha-galactosidase A (α-Gal A) deficiency. The administration of a pharmacologic chaperone (migalastat) in Fabry patients with amenable mutations has been reported to improve or stabilize organ damages and reduce lyso-Gb3 plasma level. An increase of α-Gal A activity has been observed in vitro in cells expressing amenable GLA mutations when incubated with migalastat. The impact of the drug on α-Gal A in vivo activity has been poorly studied. METHODS: We conducted a retrospective analysis of two unrelated male Fabry patients with p.Asn215Ser (p.N215S) variant. RESULTS: We report the important increase of α-Gal A activity in blood leukocytes reaching normal ranges of activity after about 1 year of treatment with migalastat. Cardiac parameters improved or stabilized with the treatment. CONCLUSION: We confirm in vivo the effects of migalastat that have been observed in N215S carriers in vitro. The increase of α-Gal A activity may be the strongest marker for biochemical efficacy. The normalization of enzyme activity could become the new therapeutic target to achieve.


Subject(s)
1-Deoxynojirimycin/analogs & derivatives , Fabry Disease , Leukocytes/enzymology , Mutation, Missense , 1-Deoxynojirimycin/administration & dosage , Administration, Oral , Amino Acid Substitution , Fabry Disease/drug therapy , Fabry Disease/enzymology , Fabry Disease/genetics , Humans , Male , Retrospective Studies , alpha-Galactosidase/genetics , alpha-Galactosidase/metabolism
3.
Molecules ; 24(2)2019 Jan 15.
Article in English | MEDLINE | ID: mdl-30650646

ABSTRACT

We have previously found two novel monoterpene glycosides, liguroside A and liguroside B, with an inhibitory effect on the catalytic activity of the enzyme leukocyte-type 12-lipoxygenase in the Qing Shan Lu Shui tea. Here, two new monoterpene glycosides, liguroside C and liguroside D which inhibit this enzyme, were isolated from the same tea. The spectral and chemical evidence characterized the structures of these compounds as (5E)-7-hydroperoxy-3,7-dimethyl-1,5-octadienyl-3-O-(α-l-rhamnopyranosyl)-(1''→3')-(4'''-O-trans-p-coumaroyl)-ß-d-glucopyranoside and (2E)-6-hydroxy-3,7-dimethyl-2,7-octadienyl-3-O-(α-l-rhamnopyranosyl)-(1''→3')-(4'''-O-trans-p-coumaroyl)-ß-d-glucopyranoside, respectively. These ligurosides, which irreversibly inhibited leukocyte-type 12-lipoxygenase, have a hydroperoxy group in the monoterpene moiety. Additionally, monoterpene glycosides had the same backbone structure but did not have a hydroperoxy group, such as kudingoside A and lipedoside B-III, contained in the tea did not inhibit the enzyme. When a hydroperoxy group in liguroside A was reduced by using triphenylphosphine, the resultant compound, kudingoside B, showed a lower inhibitory effect on the enzyme. These results strongly suggest the involvement of the hydroperoxy group in the irreversible inhibition of the catalytic activity of leukocyte-type 12-lipoxygenase by the monoterpene glycosides contained in the Qing Shan Lu Shui tea.


Subject(s)
Leukocytes/drug effects , Leukocytes/enzymology , Lipoxygenase Inhibitors/chemistry , Lipoxygenase Inhibitors/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Tea/chemistry , Arachidonate 12-Lipoxygenase/chemistry , Dose-Response Relationship, Drug , Glycosides/chemistry , Glycosides/pharmacology , Magnetic Resonance Spectroscopy , Molecular Structure , Monoterpenes/chemistry , Monoterpenes/pharmacology
4.
Fish Shellfish Immunol ; 45(2): 454-64, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25956720

ABSTRACT

The possible effect of dietary administration of fenugreek (Trigonella foenum graecum) on gilthead seabream (Sparus aurata L.) immune status and growth performance was studied. Fish were divided into 4 groups before being fed with commercial diet supplemented with 0% (control), 1%, 5% and 10% of fenugreek seeds for 4 weeks. The effects of the diets were analysed on the cellular (respiratory burst activity and leucocyte peroxidase content) and humoral (complement activity, antiprotease, total protein, peroxidase, and IgM level) immune parameters, as well as growth and haematological parameters (WBC and RBC counts). The results recorded enhancement in all the assayed parameters in fish fed fenugreek diets comparing to control fish. The expression of several immune-related genes in head-kidney (MHC1, CSF-1R, IL-8, and IgM) and different antioxidant enzyme genes in liver (GR, CAT and SOD) of seabream specimens were also investigated. Again, the highest fenugreek doses tested provoked significant up-regulation in most of immune-related genes and antioxidant enzyme genes (p < 0.05). No adverse effects were observed on intestine and liver morphology on fish fed fenugreek diets. The present results suggest that the fenugreek seed, specially the highest dosage used in the present work could be considered a good food supplement to improve the immune status and increase the production of gilthead seabream.


Subject(s)
Sea Bream/growth & development , Sea Bream/immunology , Seeds , Trigonella , Animals , Catalase/genetics , Fish Proteins/genetics , Gene Expression , Glutathione Reductase/genetics , Head Kidney/immunology , Immunoglobulin M/blood , Interleukin-8/genetics , Intestines/anatomy & histology , Leukocytes/enzymology , Liver/anatomy & histology , Liver/immunology , Peroxidase/metabolism , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Superoxide Dismutase/genetics
5.
Food Chem ; 186: 2-5, 2015 Nov 01.
Article in English | MEDLINE | ID: mdl-25976783

ABSTRACT

Oxidation of low-density lipoprotein (LDL) is one of the crucial steps for atherosclerosis development, and an essential role of leukocyte-type 12-lipoxygenase expressed in macrophages in this process has been demonstrated. The biochemical mechanism of the oxidation of circulating LDL by leukocyte-type 12-lipoxygenase in macrophages has been proposed. The major ingredients in guava tea leaves which inhibited the catalytic activity of leukocyte-type 12-lipoxygenase were quercetin and ethyl gallate. Administration of extracts from guava tea leaves to apoE-deficient mice significantly attenuated atherogenic lesions in the aorta and aortic sinus. We recently showed that Qing Shan Lu Shui inhibited the catalytic activity of leukocyte-type 12-lipoxygenase. The major components inhibiting the enzyme contained in Qing Shan Lu Shui were identified to be novel monoterpene glycosides. The anti-atherogenic effect of the tea leaves might be attributed to the inhibition of leukocyte-type 12-lipoxygenase by these components.


Subject(s)
Atherosclerosis/prevention & control , Leukocytes/enzymology , Lipoxygenase Inhibitors/chemistry , Plant Extracts/chemistry , Psidium/chemistry , Animals , Aorta/metabolism , Apolipoproteins E/genetics , Arachidonate 12-Lipoxygenase/metabolism , Dose-Response Relationship, Drug , Gallic Acid/analogs & derivatives , Gallic Acid/chemistry , Glycosides/chemistry , Inhibitory Concentration 50 , Lipoproteins, LDL/metabolism , Macrophages/enzymology , Mice , Mice, Knockout , Monoterpenes/chemistry , Oxidation-Reduction , Plant Leaves/chemistry , Quercetin/chemistry
6.
J Nutr Biochem ; 26(9): 903-11, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26025328

ABSTRACT

Demand for the vital nutrient choline is high during lactation; however, few studies have examined choline metabolism and requirements in this reproductive state. The present study sought to discern the effects of lactation and varied choline intake on maternal biomarkers of choline metabolism and breast milk choline content. Lactating (n=28) and control (n=21) women were randomized to 480 or 930 mg choline/day for 10-12 weeks as part of a controlled feeding study. During the last 4-6 weeks, 20% of the total choline intake was provided as an isotopically labeled choline tracer (methyl-d9-choline). Blood, urine and breast milk samples were collected for choline metabolite quantification, enrichment measurements, and gene expression analysis of choline metabolic genes. Lactating (vs. control) women exhibited higher (P < .001) plasma choline concentrations but lower (P ≤ .002) urinary excretion of choline metabolites, decreased use of choline as a methyl donor (e.g., lower enrichment of d6-dimethylglycine, P ≤ .08) and lower (P ≤ .02) leukocyte expression of most choline-metabolizing genes. A higher choline intake during lactation differentially influenced breast milk d9- vs. d3-choline metabolite enrichment. Increases (P ≤ .03) were detected among the d3-metabolites, which are generated endogenously via the hepatic phosphatidylethanolamine N-methyltransferase (PEMT), but not among the d9-metabolites generated from intact exogenous choline. These data suggest that lactation induces metabolic adaptations that increase the supply of intact choline to the mammary epithelium, and that extra maternal choline enhances breast milk choline content by increasing supply of PEMT-derived choline metabolites. This trial was registered at clinicaltrials.gov as NCT01127022.


Subject(s)
Choline/administration & dosage , Dietary Supplements , Lactation/metabolism , Maternal Nutritional Physiological Phenomena , Milk, Human/chemistry , Phosphatidylethanolamine N-Methyltransferase/metabolism , Adult , Biomarkers/blood , Biomarkers/urine , Choline/analysis , Choline/blood , Choline/metabolism , Cohort Studies , Deuterium , Enzyme Induction , Female , Humans , Lactation/blood , Lactation/urine , Leukocytes/enzymology , Leukocytes/metabolism , Liver/enzymology , Liver/metabolism , Mammary Glands, Human/enzymology , Mammary Glands, Human/metabolism , Milk, Human/metabolism , New York , Phosphatidylethanolamine N-Methyltransferase/chemistry , Phosphatidylethanolamine N-Methyltransferase/genetics , RNA, Messenger/metabolism , Recommended Dietary Allowances , Young Adult
7.
Int J Med Mushrooms ; 17(10): 943-55, 2015.
Article in English | MEDLINE | ID: mdl-26756186

ABSTRACT

With diabetes mellitus and increased glucose concentrations, the mitochondria electron transport chain is disrupted, superoxide anions are overproduced, and oxidative stress develops in cells. Thus, preventing oxidative stress can produce a decrease in the antioxidant system activity and an increase in apoptosis in immune cells. The application of medicinal mushrooms is a new possible approach to diabetes mellitus treatment. Therefore, the aim of this work was to investigate the influence of administration of the medicinal mushrooms Agaricus brasiliensis and Ganoderma lucidum on antioxidant enzyme activity in rat leukocytes. Wistar outbred white rats were used in the study. Streptozotocin was intraperitoneally injected once at a dose of 50 mg/kg body weight. Mushroom preparations were orally administered at a dose of 1 g/kg/day for 2 weeks. This revealed that in diabetes mellitus, the level of antioxidant enzyme activity is significantly decreased compared with control values, whereas the levels of lipid peroxidation is increased; this manifested in an increase in the amount of thiobarbituric acid reactive substances (TBARS). The medicinal mushrooms' administration is accompanied by an increase in antioxidant enzyme activity to control values and is even higher in the case of A. brasiliensis administration when compared with the diabetic group. As for the indicators of lipid peroxidation under mushroom administration of A. brasiliensis and G. lucidum, we observed a significant decrease of TBARS levels compared with the diabetic group. Increased activity of antioxidant enzymes and reduction of TBARS level indicate pronounced antioxidant properties of studied mushrooms.


Subject(s)
Agaricus , Antioxidants/pharmacology , Reishi , Animals , Catalase/metabolism , Diabetes Mellitus, Experimental/therapy , Glutathione Reductase/metabolism , Glycoproteins/metabolism , Leukocytes/enzymology , Lipid Peroxidation , Male , Oxidative Stress , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
8.
Toxicol Ind Health ; 30(3): 225-32, 2014 Apr.
Article in English | MEDLINE | ID: mdl-22865283

ABSTRACT

Probiotics are known as living, nonpathogenic microorganisms that colonize the intestine and provide benefit to the host. The present study aims to measure one important energy metabolism-related enzyme activity in blood of rabbits fed on probiotics of recommended concentration. In addition, it also aims for the evaluation of the expression level of lactate dehydrogenase (LDH) enzyme using reverse transcriptase-polymerase chain reaction (RT-PCR) technique. Two groups of rabbits are used: control group receiving normal standardized diet and the other probiotic-supplemented group receiving the same diet containing probiotic, namely, Mega acidophilus (200 million cfu/kg body weight/day) for 4 weeks. The obtained results revealed that the rabbits supplemented with probiotics showed a significant decrease in the levels of serum total cholesterol (TC), triacylglycerol, high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) when compared with control group. Risk factors detected by measuring TC/HDL-c and LDL-c/HDL-c ratios showed statistically significant decrease in probiotic-supplemented rabbits when compared with control group. In addition, blood glucose and total LDH activity were elevated in probiotic-supplemented rabbits when compared with control group. RT-PCR products of LDH-M gene produced two specific amplicons. One amplicon has the expected size of 243 bp from all samples of rabbits as revealed by GelPro software. The level of LDH-M expression was found to be increased in the probiotic-supplemented group. However, unexpected amplicons are produced at 586 bp in all the samples, which may be a dimeric form of the amplified region. It was concluded that this probiotic blend is beneficiary for the metabolic reactions of lipids in the body. Moreover, LDH expression level can be considered as a biomarker for the effect of probiotic and hence monitoring the metabolic changes as reflected from its administration.


Subject(s)
Dietary Supplements , L-Lactate Dehydrogenase/blood , Leukocytes/drug effects , Leukocytes/enzymology , Probiotics/pharmacology , Animals , Blood Glucose/drug effects , Cholesterol/blood , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/metabolism , Leukocytes/chemistry , Male , Rabbits
9.
J Vis Exp ; (75): e50246, 2013 May 22.
Article in English | MEDLINE | ID: mdl-23728273

ABSTRACT

Telomeres are repeating DNA sequences at the tip ends of the chromosomes that are diverse in length and in humans can reach a length of 15,000 base pairs. The telomere serves as a bioprotective mechanism of chromosome attrition at each cell division. At a certain length, telomeres become too short to allow replication, a process that may lead to chromosome instability or cell death. Telomere length is regulated by two opposing mechanisms: attrition and elongation. Attrition occurs as each cell divides. In contrast, elongation is partially modulated by the enzyme telomerase, which adds repeating sequences to the ends of the chromosomes. In this way, telomerase could possibly reverse an aging mechanism and rejuvenates cell viability. These are crucial elements in maintaining cell life and are used to assess cellular aging. In this manuscript we will describe an accurate, short, sophisticated and cheap method to assess telomere length in multiple tissues and species. This method takes advantage of two key elements, the tandem repeat of the telomere sequence and the sensitivity of the qRT-PCR to detect differential copy numbers of tested samples. In addition, we will describe a simple assay to assess telomerase activity as a complementary backbone test for telomere length.


Subject(s)
Cellular Senescence/physiology , Nucleic Acid Amplification Techniques/methods , Telomerase/metabolism , Telomere/chemistry , Cellular Senescence/genetics , DNA/chemistry , DNA/genetics , DNA/isolation & purification , Humans , Leukocytes/cytology , Leukocytes/enzymology , Leukocytes/ultrastructure , Reverse Transcriptase Polymerase Chain Reaction/methods , Telomere/genetics , Telomere/metabolism , Terminal Repeat Sequences
10.
Curr Cancer Drug Targets ; 13(1): 1-10, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22924417

ABSTRACT

Hyperforin is a prenylated phloroglucinol present in the medicinal plant St John's wort (Hypericum perforatum). The compound has many biological properties, including antidepressant, anti-inflammatory, antibacterial and antitumor activities. This review focuses on the in vitro antileukemic effects of purified hyperforin and related mechanisms in chronic lymphoid leukemia (CLL) and acute myeloid leukemia (AML) - conditions that are known for their resistance to chemotherapy. Hyperforin induces apoptosis in both CLL and AML cells. In AML cell lines and primary AML cells, hyperforin directly inhibits the kinase activity of the serine/threonine protein kinase B/AKT1, leading to activation of the pro-apoptotic Bcl-2 family protein Bad through its non-phosphorylation by AKT1. In primary CLL cells, hyperforin acts by stimulating the expression of the pro-apoptotic Bcl-2 family member Noxa (possibly through the inhibition of proteasome activity). Other hyperforin targets include matrix metalloproteinase-2 in AML cells and vascular endothelial growth factor and matrix metalloproteinase-9 in CLL cells - two mediators of cell migration and angiogenesis. In summary, hyperforin targets molecules involved in signaling pathways that control leukemic cell proliferation, survival, apoptosis, migration and angiogenesis. Hyperforin also downregulates the expression of P-glycoprotein, a protein that is involved in the resistance of leukemia cells to chemotherapeutic agents. Lastly, native hyperforin and its stable derivatives show interesting in vivo properties in animal models. In view of their low toxicity, hyperforin and its derivatives are promising antileukemic agents and deserve further investigation in vivo.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Myeloid, Acute/drug therapy , Phloroglucinol/analogs & derivatives , Terpenes/pharmacology , ATP Binding Cassette Transporter, Subfamily B , ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Animals , Antineoplastic Agents, Phytogenic/adverse effects , Antineoplastic Agents, Phytogenic/therapeutic use , Apoptosis/drug effects , Drug Resistance, Neoplasm/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/enzymology , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Leukemia, Myeloid, Acute/enzymology , Leukemia, Myeloid, Acute/metabolism , Leukocytes/drug effects , Leukocytes/enzymology , Leukocytes/metabolism , Neoplasm Proteins/antagonists & inhibitors , Phloroglucinol/adverse effects , Phloroglucinol/pharmacology , Phloroglucinol/therapeutic use , Proteasome Endopeptidase Complex/drug effects , Proteasome Endopeptidase Complex/metabolism , Protein Kinase Inhibitors/adverse effects , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction/drug effects , Terpenes/adverse effects , Terpenes/therapeutic use
11.
Am J Clin Nutr ; 96(4): 923-31, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22952184

ABSTRACT

BACKGROUND: A genetic variant at codon 200 (Pro200Leu) of the gene encoding for glutathione peroxidase 1 (GPx1), a selenium-dependent enzyme, is associated with lower enzyme activity; however, the evidence is limited to in vitro and observational studies. OBJECTIVE: The objective was to determine whether the GPx1 Pro200Leu genetic variants modify the response of whole-blood glutathione peroxidase (GPx) activity to selenium supplementation in patients with coronary artery disease in New Zealand. DESIGN: The results from 2 parallel-design, double-blind trials were combined. Participants were randomly assigned to receive a daily supplement of 100 µg Se as l-selenomethionine (n = 129) or placebo (n = 126) for 12 wk. Plasma selenium and whole-blood GPx activity were measured at baseline and at week 12. Participants were genotyped for the GPx1 Pro200Leu polymorphism. RESULTS: Selenium supplementation increased whole-blood GPx activity by 5 (95% CI: 4, 7) U/g hemoglobin (P < 0.001); however, the magnitude of the increase did not differ by genotype (P = 0.165 for treatment-by-genotype interaction). In an exploratory analysis, a significant nutrient-gene interaction was apparent when baseline plasma selenium concentrations were included in the regression model (P = 0.006 for treatment-by-genotype × baseline selenium concentration interaction). Increases in GPx activity were 2-fold higher in Pro homozygotes than in participants carrying a Leu allele when baseline selenium concentrations were ≤1.15 µmol/L (P < 0.05). CONCLUSIONS: These results indicate that GPx1 Pro200Leu variants do not substantially modify the response of whole-blood GPx to selenium supplementation in individuals with relatively high plasma selenium concentrations. A nutrient-gene interaction was observed when the baseline selenium concentration was low, but this requires independent confirmation. This trial was registered at www.actr.org.au as ACTRN12605000412639 and ACTRN12606000197538.


Subject(s)
Coronary Artery Disease/blood , Coronary Artery Disease/genetics , Glutathione Peroxidase/blood , Glutathione Peroxidase/genetics , Oxidative Stress , Polymorphism, Single Nucleotide , Selenium/metabolism , Adult , Aged , Aged, 80 and over , Amino Acid Substitution , Coronary Artery Disease/diet therapy , Coronary Artery Disease/metabolism , Dietary Supplements , Double-Blind Method , Enzyme Induction , Female , Follow-Up Studies , Genetic Association Studies , Glutathione Peroxidase/metabolism , Humans , Leukocytes/enzymology , Leukocytes/metabolism , Middle Aged , New Zealand , Selenium/blood , Selenium/therapeutic use , Selenomethionine/administration & dosage , Glutathione Peroxidase GPX1
12.
J Med Primatol ; 41(6): 372-83, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22978812

ABSTRACT

BACKGROUND: Previous analysis of aromatase gene and protein expression in peripheral blood leucocytes (PBLs), studied in children and adults, was extended to elderly subjects. In addition, we assessed whether aromatase expression in PBLs could be used as a parameter of aromatase expression in other tissues, using the cynomolgus monkey as model. METHODS: Real-time PCR analysis of aromatase gene expression and protein evaluation by Western blot was performed in PBLs of human elderly subjects and in various tissues from cynomolgus monkeys. RESULTS: No gender-related difference in CYP19A1 mRNA and protein expression in PBLs from human elderly women and men was found. In elderly male cynomolgus monkeys, CYP19A1 mRNA and protein were expressed in all cells and tissues analysed, with the lowest levels in PBLs but no clear-cut correlation with other tissues. CONCLUSIONS: Aromatase expression in PBLs in elderly human subjects is not gender-related and cannot be a surrogate of aromatase expression for other tissues.


Subject(s)
Aromatase/genetics , Gene Expression , Leukocytes/enzymology , Macaca fascicularis/metabolism , Aged , Aged, 80 and over , Aging , Animals , Aromatase/analysis , Aromatase/blood , Epididymis/enzymology , Estradiol/blood , Female , Fibroblasts/enzymology , Humans , Hypothalamus/enzymology , Liver/enzymology , Male , Middle Aged , RNA, Messenger/analysis , RNA, Messenger/blood , Real-Time Polymerase Chain Reaction , Testis/enzymology , Testosterone/blood
13.
Benef Microbes ; 3(1): 77-81, 2012 Mar 01.
Article in English | MEDLINE | ID: mdl-22348912

ABSTRACT

In the present study, a feeding trial was conducted to evaluate the effect of inulin and heat-inactivated Bacillus subtilis, single or combined, on several innate immune activities of gilthead seabream (Sparus aurata). Forty-eight specimens were randomly assigned to four dietary treatments: 0 (control), inulin (10 g/kg, prebiotic group), B. subtilis (10(7) cfu/g, probiotic group), or B. subtilis + inulin (10(7) cfu/g + 10 g/kg, synbiotic group). After two and four weeks, six fish of each group were sampled, with the main innate immune parameters (natural haemolytic complement activity, serum and leucocyte peroxidase, phagocytosis, respiratory burst, and cytotoxic activities) being determined. Inulin or heat-inactivated B. subtilis failed to significantly stimulate the innate immune parameters assayed, although some activities showed no significant increase through these treatments. A combination of inulin and B. subtilis resulted in an increase of such parameters, with the haemolytic complement activity being the only one significantly stimulated. To conclude, inulin and B. subtilis, when administered as a synbiotic, have a synergistic effect and enhance some innate immune parameters of gilthead seabream.


Subject(s)
Bacillus subtilis/immunology , Immunity, Innate , Inulin/pharmacology , Sea Bream/immunology , Synbiotics , Animals , Complement System Proteins/immunology , Dietary Supplements , Drug Evaluation , Hot Temperature , Inulin/administration & dosage , Leukocytes/enzymology , Phagocytosis , Respiratory Burst
14.
Clin Pharmacol Ther ; 91(2): 289-97, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22205191

ABSTRACT

Hypertension is associated with endothelial dysfunction and activated Rho-associated kinases (ROCKs). The purpose of this study was to evaluate the effects of the selective mineralocorticoid receptor blocker, eplerenone, on endothelial function and ROCK activity in patients with hypertension. The study was carried out over 48 weeks in 60 untreated patients with hypertension who were randomly assigned to eplerenone, nifedipine, and losartan groups. We evaluated the effects of each treatment on flow-mediated vasodilation (FMD) and ROCK activity in peripheral leukocytes. Eplerenone increased FMD and decreased leukocyte ROCK activity. Nifedipine decreased ROCK activity but did not alter FMD. Losartan increased FMD but did not alter ROCK activity. Hypotensive effects were similar in the three groups, as was nitroglycerin-induced vasodilation during the follow-up period. There were no significant differences between the groups with respect to other parameters. The study results show that eplerenone improves endothelial function and inhibits ROCK activity in patients with essential hypertension.


Subject(s)
Endothelium, Vascular/drug effects , Hypertension/drug therapy , Mineralocorticoid Receptor Antagonists/pharmacology , Mineralocorticoid Receptor Antagonists/therapeutic use , Spironolactone/analogs & derivatives , rho-Associated Kinases/antagonists & inhibitors , Angiotensin II Type 1 Receptor Blockers/pharmacology , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Calcium Channel Blockers/pharmacology , Calcium Channel Blockers/therapeutic use , Cell Movement/drug effects , Endothelium, Vascular/physiology , Eplerenone , Female , Humans , Hypertension/enzymology , Hypertension/physiopathology , Leukocytes/enzymology , Losartan/pharmacology , Losartan/therapeutic use , Male , Middle Aged , Nifedipine/pharmacology , Nifedipine/therapeutic use , Nitroglycerin/pharmacology , Spironolactone/pharmacology , Spironolactone/therapeutic use , Stem Cells/drug effects , Vascular Endothelial Growth Factor A/agonists , Vasodilation/drug effects , Vasodilation/physiology
15.
J Nutr Biochem ; 23(9): 1170-7, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22137268

ABSTRACT

Moderate selenium deficiency may lead to an impaired capacity to cope with health challenges. Functional effects of suboptimal selenium intake are not fully known, and biomarkers for an insufficient selenium supply are inadequate. We therefore fed mice diets of moderately deficient or adequate selenium intake for 6 weeks. Changes in global gene expression were monitored by microarray analysis in splenic leukocytes. Genes for four selenoproteins, Sepw1, Gpx1, Selh and Sep15, were the most significantly down-regulated in moderate selenium deficiency, and this was confirmed by quantitative polymerase chain reaction (qPCR). Classification of significantly affected genes revealed that processes related to inflammation, heme biosynthesis, DNA replication and transcription, cell cycle and transport were affected by selenium restriction. Down-regulation by moderate selenium deficiency of specific genes involved in inflammation and heme biosynthesis was confirmed by qPCR. Myeloperoxidase and lysozyme activities were decreased in selenium-restricted leukocytes, providing evidence for functional consequences. Genes for 31 nuclear factor (NF)-κB targets were down-regulated in moderate selenium deficiency, indicating an impaired NF-κB signaling. Together, the observed changes point to a disturbance in inflammatory response. The selenoproteins found here to be sensitive to selenium intake in murine leukocytes might also be useful as biomarkers for a moderate selenium deficiency in humans.


Subject(s)
Down-Regulation , Leukocytes/metabolism , Selenium/deficiency , Selenoproteins/metabolism , Spleen/immunology , Animals , Biomarkers/metabolism , Gene Expression Profiling , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Leukocytes/enzymology , Leukocytes/immunology , Leukocytes/pathology , Male , Mice , Mice, Inbred C57BL , Muramidase/metabolism , Oligonucleotide Array Sequence Analysis , Peroxidase/metabolism , RNA, Messenger/metabolism , Selenium/blood , Selenium/metabolism , Selenium/therapeutic use , Selenoprotein W/genetics , Selenoprotein W/metabolism , Selenoproteins/genetics , Severity of Illness Index , Spleen/pathology , Up-Regulation , Glutathione Peroxidase GPX1
16.
Fish Shellfish Immunol ; 32(2): 339-44, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22155010

ABSTRACT

The effect of Coriolus versicolor extract supplemented diets on innate immune response and disease resistance in kelp grouper, Epinephelus bruneus against Listonella anguillarum, is reported. Kelp grouper were divided into four groups of 25 each and fed with C. versicolor enriched diets at 0% (control), 0.01%, 0.1%, and 1.0% level. After 30 days of feeding, all fish were injected interaperitoneally (i.p.) with 50 µl of L. anguillarum (4.7 × 10(7) CFU) to investigate the immune parameters at weeks 1, 2, and 4. The reactive oxygen species and reactive nitrogen species production were significantly enhanced in fish fed with 0.1% and 1.0% supplementation diets from weeks 1-4 when compared to the non enriched diet fed and infected control. The phagocytic activity significantly increased with 0.1% and 1.0% diets on weeks 2 and 4. The leucocyte myeloperoxidase content, lysozyme activity, and total protein level significantly increased when fed with 0.1% and 1.0% supplementation diets from weeks 1-4. The cumulative mortality was 35% and 45% in 1.0% and 0.1% enriched diet fed groups whereas it was 55% and 80% in 0.01% and 0% groups respectively. The present results suggest that diets enriched with C. versicolor at 0.1% or 1.0% level positively enhance the innate immune system and affords protection from L. anguillarum.


Subject(s)
Bass/immunology , Dietary Supplements , Fish Diseases/prevention & control , Gram-Negative Bacterial Infections/veterinary , Immunity, Innate/immunology , Listonella/immunology , Animals , Bass/microbiology , Blood Proteins/analysis , Disease Resistance/immunology , Gram-Negative Bacterial Infections/prevention & control , Leukocytes/enzymology , Muramidase/metabolism , Peroxidase/metabolism , Phagocytosis/immunology , Reactive Nitrogen Species/immunology , Reactive Oxygen Species/immunology , Time Factors
17.
Lipids Health Dis ; 10: 213, 2011 Nov 16.
Article in English | MEDLINE | ID: mdl-22087726

ABSTRACT

BACKGROUND: Platelet activating factor (PAF) has been proposed as a key factor and initial trigger in atherosclerosis. Recently, a modulation of PAF metabolism by bioactive food constituents has been suggested. In this study we investigated the effect of fish polar lipid consumption on PAF metabolism. RESULTS: The specific activities of four PAF metabolic enzymes; in leukocytes, platelets and plasma, and PAF concentration; either in blood cells or plasma were determined. Samples were acquired at the beginning and at the end of a previously conducted study in male New Zealand white rabbits that were fed for 45 days with atherogenic diet supplemented (group-B, n = 6) or not (group-A, n = 6) with gilthead sea bream (Sparus aurata) polar lipids.The specific activity of PAF-Acetylhydrolase (PAF-AH); a catabolic enzyme of PAF, was decreased in rabbits' platelets of both A and B groups and in rabbits' leukocytes of group A (p < 0.05). On the other hand the specific activity of Lipoprotein-associated Phospholipase A2 (Lp-PLA2); the catabolic enzyme of PAF in plasma was increased in both A and B groups in both leukocytes and platelets (p < 0.05). PAF-cholinephosphotransferase (PAF-CPT); a biosynthetic enzyme of PAF showed increased specific activity only in rabbits' leukocytes of group A (p < 0.05). Neither of the two groups showed any change in Lyso-PAF-acetyltransferase (Lyso-PAF-AT) specific activity (p > 0.05). Free and bound PAF levels increased in group A while decreased in group B (p < 0.05). CONCLUSIONS: Gilthead sea bream (Sparus aurata) polar lipids modulate PAF metabolism upon atherosclerotic conditions in rabbits leading to lower PAF levels and activity in blood of rabbits with reduced early atherosclerotic lesions compared to control group.


Subject(s)
Atherosclerosis/drug therapy , Enzyme Activators/therapeutic use , Fish Oils/therapeutic use , Gene Expression Regulation/drug effects , Platelet Activating Factor/biosynthesis , 1-Alkyl-2-acetylglycerophosphocholine Esterase/genetics , 1-Alkyl-2-acetylglycerophosphocholine Esterase/metabolism , Animals , Atherosclerosis/enzymology , Atherosclerosis/prevention & control , Blood Platelets/enzymology , Diacylglycerol Cholinephosphotransferase/genetics , Diacylglycerol Cholinephosphotransferase/metabolism , Diet, Mediterranean , Enzyme Activators/chemistry , Enzyme Activators/pharmacology , Fatty Acids/chemistry , Fish Oils/chemistry , Fish Oils/pharmacology , Gene Expression , Leukocytes/enzymology , Male , Platelet Activating Factor/metabolism , Rabbits , Sea Bream
18.
Urologiia ; (1): 44-6, 2011.
Article in Russian | MEDLINE | ID: mdl-21500493

ABSTRACT

Modelling of transurethral resection (TUR) of the prostate on the animals has shown that changes in the region of postoperative wound progress by inflammatory stages--primary, then secondary alteration. These changes are confirmed by the morphological picture, shifts in enzyme levels, findings of the spectral analysis typical for systemic inflammatory reaction. Approaches to prevention of early postoperative complications based on principal components of pathogenesis are proposed.


Subject(s)
Postoperative Complications/prevention & control , Prostate/surgery , Transurethral Resection of Prostate , Animals , Leukocytes/enzymology , Leukocytes/pathology , Male , Microcirculation , Necrosis , Postoperative Complications/blood , Postoperative Complications/pathology , Prostate/blood supply , Prostate/enzymology , Prostate/pathology , Rats , Time Factors
19.
Fish Shellfish Immunol ; 30(3): 972-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21300159

ABSTRACT

Effect of diet enriched with green tea at 0, 0.01, 0.1 or 1.0% levels on immune responses such as non-specific humoral (lysozyme, antiprotease and complement) and cellular (myeloperoxidase content, production of reactive oxygen, and nitrogen species) and disease resistance on week 1, 2 or 4 in kelp grouper Epinephelus bruneus challenged with Vibrio carchariae (2.47 × 10(8) CFU ml(-1)) was quantified. At all doses green tea supplementation significantly enhanced the serum lysozyme activity from weeks 1 to 4. On the other hand, after week 2 the serum hemolytic complement activity, leucocyte myeloperoxidase content and reactive nitrogen species protection significantly increased in groups fed with 0.01 and 0.1% green tea supplementation diets. The serum antiprotease activity significantly increased in group fed with at 1.0% green tea from week 1 to 4. However, all diets except at 0.01% level resulted in a significant decrease in reactive oxygen species protection during the experimental period. Challenged groups fed with green tea enriched diet at 0.01 and 0.1% level had a higher relative percent survival than with 1.0% diet on week 1, 2 or 4. The results suggest that dietary administration of green tea supplementation at a concentration of 0.01 and 0.1% level positively enhances the non-specific humoral and cellular immune responses and disease resistance of kelp grouper E. bruneus to V. carchariae.


Subject(s)
Bass/immunology , Diet/veterinary , Fish Diseases/immunology , Immunity, Cellular/immunology , Immunity, Humoral/immunology , Immunity, Innate/immunology , Tea/immunology , Vibrio Infections/veterinary , Animals , Enzymes/blood , Enzymes/immunology , Fish Diseases/mortality , Leukocytes/enzymology , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Survival Analysis , Vibrio/physiology , Vibrio Infections/immunology , Vibrio Infections/mortality
20.
Fish Shellfish Immunol ; 30(1): 397-405, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21126585

ABSTRACT

Head kidney leukocytes isolated from Atlantic salmon fed either a diet based on fish oil (FO) or soy bean oil (VO) were used in order to evaluate if different lipid sources could contribute to cellular activation of the salmon innate immune system. A specific inhibitor of p38 MAPK, SB202190, was used to investigate the effect of lipopolysaccharide (LPS) signalling in the head kidney leukocytes. The results show that LPS up regulate IL-1ß, TNF-α, Cox2 expression in leukocytes isolated from fish fed either diet. The p38 MAPK inhibitor, SB202190, reduced the LPS induced expression of these genes in both dietary groups. In LPS stimulated leukocytes isolated from VO fed fish, SB202190 showed a clear dose dependent inhibitory effect on IL-1ß, TNF-α and Cox2 expression. This effect was also observed for Cox2 in leukocytes isolated from FO fed fish. Furthermore, there was a stronger mean induction of Cox2 in LPS stimulated leucocytes isolated from the VO-group compared to LPS stimulated leukocytes isolated from the FO-group. In both dietary groups, LPS stimulation of salmon head kidney leukocytes increased the induction of CD83, a dendrite cell marker, while the inhibitor reduced CD83 expression in the VO fed fish only. The inhibitor also clearly reduced hsp27 expression in VO fed fish. Indicating a p38 MAPK feedback loop, LPS significantly inhibited the expression of p38MAPK itself in both diets, while SB202190 increased p38MAPK expression especially in the VO diet group. hsp70 expression was not affected by any treatment or feed composition. There were also differences in p38MAPK protein phosphorylation comparing treatment groups but no obvious difference comparing the two dietary groups. The results indicate that dietary fatty acids have the ability to modify signalling through p38 MAPK which may have consequences for the fish's ability to handle infections and stress. Signalling through p38MAPK is ligand dependent and affects gene and protein expression differently.


Subject(s)
Diet/veterinary , Fish Oils/pharmacology , Gene Expression Regulation/drug effects , Leukocytes/enzymology , Salmo salar , Soybean Oil/pharmacology , Animal Feed , Animal Nutritional Physiological Phenomena , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Cells, Cultured , Cytokines/genetics , Cytokines/metabolism , HSP27 Heat-Shock Proteins/genetics , HSP27 Heat-Shock Proteins/metabolism , HSP70 Heat-Shock Proteins/genetics , HSP70 Heat-Shock Proteins/metabolism , Immunoglobulins/genetics , Immunoglobulins/metabolism , Leukocytes/drug effects , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Phagocytosis/drug effects , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism , CD83 Antigen
SELECTION OF CITATIONS
SEARCH DETAIL